Novel scavenger receptor
CA 2399865 C · Owner: Fuso Pharmaceutical Industries, Ltd. · Inventors: Wakamiya, Nobutaka
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel scavenger receptors having an SR structure and a collectin-like structure are provided, which can be utilized in the elucidation of mechanisms of , macrophage and basic immunity; in the elucidation of mechanisms of the development of a wide variety of diseases such as arteriosclerosis diabetic , complications and Alzheimer's disease hyper .beta.-lipoproteinemia, hypercholesterolemia hypertriglyceridemia, hypo .alpha.-lipoproteinemia transplantation, atherectomy, post angiogenic restenosis bacterial , infections; in the , diagnostic prophylactic and therapeutic methods thereof; and in the development , of reagents and drugs for the same. The novel scavenger receptors include …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 8, 2001 and granted October 25, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 8, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 8, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.